Prosecution Insights
Last updated: April 19, 2026

Nevro Corp.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18531474 SYSTEMS AND METHODS FOR PRODUCING ASYNCHRONOUS NEURAL RESPONSES TO TREAT PAIN AND/OR OTHER PATIENT CONDITIONS MANUEL, GEORGE C 3792 Non-Final OA Dec 06, 2023
18352846 SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION, INCLUDING REDUCED DOSES OF NEUROSTIMULATION ALTER MORSCHAUSER, ALYSSA MARGO 3796 Non-Final OA Jul 14, 2023
17991810 THERAPEUTIC MODULATION TO TREAT BLOOD GLUCOSE ABNORMALITIES, INCLUDING TYPE 2 DIABETES, AND/OR REDUCE HBA1C LEVELS, AND ASSOCIATED SYSTEMS AND METHODS BAIG, RUMAISA RASHID 3796 Non-Final OA Nov 21, 2022
17173725 MOLDED HEADERS FOR IMPLANTABLE SIGNAL GENERATORS, AND ASSOCIATED SYSTEMS AND METHODS SCHAETZLE, KENNEDY 3796 Final Rejection Feb 11, 2021

Managing Nevro Corp.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month